Human Longevity Inc. logo

Human Longevity Inc.

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

6

Funding Rounds

$399.8m

Money raised

Overview

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

Funding

Funding series

Funding Series Analysis

The company Human Longevity Inc. has raised a total of $149.8m in funding over 6 rounds.

Key Insights:

  • Human Longevity August 2024 Series B Funding Round: $39.8m
  • Human Longevity Inc. Series C round, November 7, 2019: $30m
  • Human Longevity Inc. Series A round, March 4, 2014: $80m
  • Human Longevity Series B round: $220m
  • Human Longevity, Inc. funding round, July 2019: $30.03m
Human Longevity Inc. logo
Human Longevity August 2024 Series B Funding Round $39.8m
Human Longevity Inc. logo
Human Longevity Inc. Series C round, November 7, 2019 $30m
Human Longevity Inc. logo
Human Longevity Inc. Series A round, March 4, 2014 $80m
Human Longevity Inc. logo
Human Longevity, Inc. funding round, July 2019 $30.03m
Human Longevity Inc. logo
Human Longevity Series B round $220m

Industries

Human Longevity Inc. is active in the following industries:
  • Genetics
  • Healthcare
  • Database
  • Bioinformatics
  • Therapeutics
  • Machine learning
  • Microbiome
  • Oncology
  • Therapy
  • Ageing
  • Molecular diagnostics
  • Consumer biotechnology
  • Biomedical engineering
  • Diagnosis
  • Electronic health record
  • Anti-Aging
  • Engineering
  • Artificial Intelligence (AI)
  • Technology
  • Biology
  • Biotechnology
  • Internal medicine
  • Digital health
  • Medicine